跳至主要内容
临床试验/NCT05705011
NCT05705011已完成不适用

Frailty, Cognitive Function and Health-related Quality of Life in Older Adults With Advanced Chronic Kidney Disease: Mortality and Dialysis Initiation, a Prospective Cohort Study.

Grigore T. Popa University of Medicine and Pharmacy1 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2019年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
240
试验地点
1
主要终点
Time to initiate dialysis.

研究概览

简要总结

This observational study explores the impact of cognitive impairment and frailty in older adults with advanced chronic kidney disease ].

The main question[s] it aims to answer are:

  • What determines the time to initiate dialysis? Cognitive impairment or frailty?
  • What does predict the time to death? Presence of frailty or cognitive impairment?
  • What does correlate strongly with time-low health-related quality of life? frailty or cognitive impairment?

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients age 65 years or older.
  • CKD stage 4 and 5 who were identified by two consecutive measurements of estimated glomerular filtration rate (eGFR) <30 mL/min/1.73 m2 separated by more than 3 months.

排除标准

  • Patients younger than 65 years old.
  • Chronic kidney disease stages 1,2, and
  • Dialysis dependence
  • History of kidney transplantation.
  • Initial visit with the health care provider.
  • Recent acute kidney injury.
  • Patients who had been hospitalized for more than 2 months before the visit (because long hospitalization might affect the degree of frailty)
  • Patients with myocardial infarction and cerebrovascular accident 3 months before the assessment
  • Patients who are blind or with limb amputation.
  • Patients who refuse to participate.

结局指标

主要结局

Time to initiate dialysis.

时间窗: 36 months

The time from the assessment moment to start dialysis of an older adult with advanced CKD (

Time to death

时间窗: 36 months

The time from the assessment moment to death of an older adult with advanced CKD ( CKD stage 4 and 5).

次要结局

未报告次要终点

研究者

发起方
Grigore T. Popa University of Medicine and Pharmacy
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hani Hussien

Doctor

Grigore T. Popa University of Medicine and Pharmacy

研究点 (1)

Loading locations...

相似试验